Regulatory T cells and infection: A dangerous necessity

Nature Reviews Immunology

Volumn 7, Issue 11, 2007, Pages 875-888

  Belkaid, Yasmine ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANTIGEN SPECIFICITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFECTION CONTROL; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; HUMANS; INFECTION; T-LYMPHOCYTES, REGULATORY;

EID: 34748873441     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2189     Document Type: Review

References (141)

1. Sacks, D. & Sher, A. Evasion of innate immunity by parasitic protozoa. Nature Immunol. 3, 1041-1047 (2002).
2. Mahanty, S. et al. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J. Infect. Dis. 173, 769-773 (1996).
3. + Tregs: limiting collateral damage. J. Clin. Invest. 114, 1372-1378 (2004).
4. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
5. + regulatory T cells. Immunol. Rev. 212, 60-73 (2006).
6. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
7. Yamaguchi, T. et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27, 145-159 (2007).
8. Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83-92 (2006).
9. von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nature Immunol. 6, 338-344 (2005).
10. Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206-1212 (2003).
11. Bopp, T. et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310 (2007).
12. Powrie, F., Read, S., Mottet, C., Uhlig, H. & Maloy, K. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252, 92-98 (2003).
13. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172, 4123-4132 (2004).
14. Hesse, M. et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172, 3157-3166 (2004).
15. Reg cells accumulate at sites of infection and mediate microbial persistence while maintaining immunity to re-infection.
16. Reg cells can excessively limit effector responses and thereby lead to death of the host.
17. Taylor, M. D. et al. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. 174, 4924-4933 (2005).
18. + T-cell expansion and TGFβ levels.
19. + T cells accumulate in the lymphoid tissues of patients infected with HIV.
20. Rouse, B. T., Sarangi, P. P. & Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 212, 272-286 (2006).
21. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331-343 (2004).
22. Andersson, J. et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174, 3143-3147 (2005).
23. Kornfeld, C. et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115, 1082-1091 (2005).
24. + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108, 3072-3078 (2006).
25. Pereira, L. E. et al. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J. Virol. 81, 4445-4456 (2007).
26. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177, 739-747 (2006).
27. Sugimoto, K. et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38, 1437-1448 (2003).
28. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40, 1062-1071 (2004).
29. + T cell response in HCVinfected patients with normal versus abnormal alanine aminotransferase levels. Clin. Exp. Immunol. 144, 188-196 (2006).
30. + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103, 3428-3430 (2004).
31. + T cell receptors. Immunity 21, 267-277 (2004).
32. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173, 1224-1231 (2004).
33. Hisaeda, H. et al. Resistance of regulatory T cells to glucocorticoid-induced TNFR family-related protein (GITR) during Plasmodium yoelii infection. Eur. J. Immunol. 35, 3516-3524 (2005).
34. Reg cells from peripheral-blood mononuclear cells of HIV-infected patients reveals antigen-specific responses against HIV.
35. MacDonald, A. J. et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185, 720-727 (2002).
36. Reg cells can also recognize microbial antigens.
37. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200, 201-210 (2004).
38. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
39. Hoffmann, K. F., Cheever, A. W. & Wynn, T. A. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164, 6406-6416 (2000).
40. Gazzinelli, R. T., Oswald, I. P., James, S. L. & Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148, 1792-1796 (1992).
41. Li, C., Corraliza, I. & Langhorne, J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67, 4435-4442 (1999).
42. Plebanski, M. et al. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 10, 651-660 (1999).
43. Boussiotis, V. A. et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105, 1317-1325 (2000).
44. Mahanty, S. et al. Regulation of parasite antigendriven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect. Immun. 65, 1742-1747 (1997).
45. Carvalho, E. M. et al. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152, 5949-5956 (1994).
46. King, C. L. et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J. Immunol. 156, 4715-4721 (1996).
47. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157, 798-805 (1996). This study, together with reference 37, indicates the paradoxical effect of IL-10. In the absence of this regulatory cytokine, the host can efficiently control microbial infection but dies because of uncontrolled immune responses.
48. Ramalingam, T. R., Reiman, R. M. & Wynn, T. A. Exploiting worm and allergy models to understand Th2 cytokine biology. Curr. Opin. Allergy Clin. Immunol. 5, 392-398 (2005).
49. Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M. & Mosser, D. M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201, 747-754 (2005).
50. Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
51. McGuirk, P., McCann, C. & Mills, K. H. Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231 (2002).
52. Van der Kleij, D. et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAcβ1- 4(Fucα1-2Fucα1-3) GlcNAc. J. Infect. Dis. 185, 531-539 (2002). References 51 and 52 identify microbial products that can specifically induce IL-10-producing T cells with regulatory properties.
53. Marshall, N. A., Vickers, M. A. & Barker, R. N. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J. Immunol. 170, 6183-6189 (2003).
54. Marshall, N. A. et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103, 1755-1762 (2004).
55. Del Prete, G. et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353-360 (1993).
56. + T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92, 224-234 (1999).
57. Pohl-Koppe, A., Balashov, K. E., Steere, A. C., Logigian, E. L. & Hafler, D. A. Identification of a T cell subset capable of both IFN-γ and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J. Immunol. 160, 1804-1810 (1998).
58. Trinchieri, G. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. J. Exp. Med. 194, F53-F57 (2001).
59. +Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007).
60. H1 cells that produce IL-10 have regulatory properties.
61. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
62. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
63. - T cells. Int. Immunol. 16, 1203-1213 (2004).
64. Wan, Y. Y. & Flavell, R. A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl Acad. Sci. USA 102, 5126-5131 (2005).
65. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
66. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nature Immunol. 6, 1219-1227 (2005).
67. Barnard, J. A., Warwick, G. J. & Gold, L. I. Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology 105, 67-73 (1993).
68. + T cells. Eur. J. Immunol. 34, 1059-1067 (2004).
69. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341 (2005).
70. Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
71. Montagnoli, C. et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712-1723 (2006).
72. Spiegel, A., Tall, A., Raphenon, G., Trape, J. F. & Druilhe, P. Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 97, 198-199 (2003).
73. La Flamme, A. C., Ruddenklau, K. & Backstrom, B. T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71, 4996-5004 (2003).
74. Zaccone, P. et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33, 1439-1449 (2003).
75. Elliott, D. E. et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest Liver Physiol. 284, G385-G391 (2003).
76. Wilson, M. S. & Maizels, R. M. Regulatory T cells induced by parasites and the modulation of allergic responses. Chem. Immunol. Allergy 90, 176-195 (2006).
77. Correale, J. & Farez, M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61, 97-108 (2007). This work suggests that regulatory T cells that are induced during helminth infection in humans can have a protective effect against autoimmune disorders.
78. Wills-Karp, M., Santeliz, J. & Karp, C. L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev. Immunol. 1, 69-75 (2001).
79. Maizels, R. M. Infections and allergy - helminths, hygiene and host immune regulation. Curr. Opin. Immunol. 17, 656-661 (2005).
80. Reg cells activated during helminth infections protect from excessive immune responses in an experimental model of asthma.
81. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W. & Boirivant, M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174, 3237-3246 (2005).
82. de Oliveira, M. R. et al. Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice. Rev. Inst. Med. Trop. São Paulo 41, 87-94 (1999).
83. Singer, S. M. & Nash, T. E. The role of normal flora in Giardia lamblia infections in mice. J. Infect. Dis. 181, 1510-1512 (2000).
84. Enarsson, K. et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin. Immunol. 121, 358-368 (2006).
85. Sutmuller, R. P. et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494 (2006).
86. + T regulatory cells. J. Immunol. 175, 8051-8059 (2005).
87. Sutmuller, R. P., Morgan, M. E., Netea, M. G., Grauer, O. & Adema, G. J. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 27, 387-393 (2006).
88. + regulatory T cells. Proc. Natl Acad. Sci. USA 103, 7048-7053 (2006).
89. Netea, M. G. et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718 (2004).
90. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
91. Nilsson, J. et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108, 3808-3817 (2006).
92. Grant, C. et al. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog. 2, e33 (2006).
93. + cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J. Virol. 80, 10162-10172 (2006).
94. Reg and control of Leishmania major infection. J. Immunol. 174, 5444-5455 (2005).
95. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203, 2451-2460 (2006).
96. + T lymphocytes with regulatory activity. J. Immunol. 166, 996-1002 (2001).
97. + T cells, which regulate Th2-mediated granuloma formation in mice. J. Immunol. 174, 1962-1970 (2005).
98. Belkaid, Y. & Rouse, B. T. Natural regulatory T cells in infectious disease. Nature Immunol. 6, 353-360 (2005).
99. He, H. et al. Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. J. Virol. 78, 11641-11647 (2004).
100. + T cells. J. Immunol. 173, 5008-5020 (2004).
101. + T cell responses. J. Exp. Med. 198, 889-901 (2003).
102. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 8, 191-197 (2007).
103. + regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335-1347 (2007).
104. + T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 107, 4424-4432 (2006).
105. + T cell responses. J. Exp. Med. 196, 1585-1592 (2002).
106. Reg-cell function can enhance the efficiency of vaccines against microbial infections.
107. + T cell response primed by DNA immunization. World J. Gastroenterol. 11, 3772-3777 (2005).
108. Moore, A. C. et al. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J. Immunol. 175, 7264-7273 (2005).
109. + T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J. Immunol. 174, 3344-3351 (2005). References 108 and 109 show that limiting regulatory T cells at the time of vaccination can favour responses to subdominant antigens.
110. Shaw, M. H. et al. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-γ-dependent IL-10 reactivation. J. Immunol. 176, 7263-7271 (2006).
111. Gurunathan, S. et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186, 1137-1147 (1997).
112. Stober, C. B., Lange, U. G., Roberts, M. T., Alcami, A. & Blackwell, J. M. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J. Immunol. 175, 2517-2524 (2005). This study indicates that vaccination can also induce regulatory T cells that can interfere with the efficiency of the protective immune response.
113. Tabbara, K. S. et al. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect. Immun. 73, 4714-4722 (2005).
114. + T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged γ interferon-deficient mice treated with anti-interleukin-17 antibody. Clin. Diagn. Lab. Immunol. 11, 1075-1084 (2004).
115. + T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major. J. Immunol. 165, 5637-5645 (2000).
116. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
117. Singh, K. P., Gerard, H. C., Hudson, A. P., Reddy, T. R. & Boros, D. L. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 114, 410-417 (2005).
118. van der Kleij, D. et al. A novel host-parasite lipid crosstalk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277, 48122-48129 (2002).
119. Braat, H. et al. Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule. Gut 56, 351-357 (2007).
120. Belkaid, Y., Blank, R. B. & Suffia, I. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 212, 287-300 (2006).
121. Taylor, J. J., Mohrs, M. & Pearce, E. J. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 176, 5839-5847 (2006).
122. + T cells in spleens and mesenteric lymph nodes of mice infected with Schistosoma japonicum. Acta Biochim. Biophys. Sin (Shanghai) 38, 299-304 (2006).
123. + T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J. Infect. Dis. 193, 1313-1322 (2006).
124. Kitagaki, K. et al. Intestinal helminths protect in a murine model of asthma. J. Immunol. 177, 1628-1635 (2006).
125. + T cell function by Friend virus-induced regulatory T cells. J. Immunol. 176, 3342-3349 (2006).
126. + regulatory T cell responses during Friend retrovirus infection. Eur. J. Immunol. 36, 2658-2670 (2006).
127. + T cells during chronic hepatitis C virus infection. J. Virol. 79, 7860-7867 (2005).
128. - regulatory T cells in chronic hepatitis C virus infection. Immunol. Cell Biol. 85, 197-204 (2007).
129. Stoop, J. N., van der Molen, R. G., Kuipers, E. J., Kusters, J. G. & Janssen, H. L. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 361, 141-148 (2007).
130. + regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int. Immunol. 19, 133-140 (2007).
131. + T cells in patients with HTLV-I-associated neuroimmunological disease. J. Clin. Invest. 115, 1361-1368 (2005).
132. Oh, U. et al. Reduced Foxp3 protein expression is associated with inflammatory disease during human T lymphotropic virus type 1 Infection. J. Infect. Dis. 193, 1557-1566 (2006).
133. + T-cell phenotype associated with HTLV-1 infection. J. Invest. Dermatol. 126, 690-692 (2006).
134. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78, 2454-2459 (2004).
135. Estes, J. D. et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193, 703-712 (2006).
136. Cavassani, K. A. et al. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol. 177, 5811-5818 (2006).
137. + regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect. Immun. 74, 3519-3529 (2006).
138. McKinley, L. et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J. Immunol. 177, 6215-6226 (2006).
139. + regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol. Cell Biol. 84, 467-474 (2006).
140. + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123, 50-59 (2007).
141. Faal, N. et al. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med. 3, e266 (2006).